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Purpose: We hypothesized that pulmonary vein (PV) orientation inﬂuences tissue contact of the contact force
(CF) sensing radiofrequency ablation catheter (CFC) and therefore atrial ﬁbrillation (AF) free survival after
pulmonary vein isolation (PVI). The aim of this study was to determine the association between PV orientation,
CF and AF free survival in patients undergoing CFC PVI.
Methods: Sixty consecutive patients undergoing CFC PVI were included. ECG-triggered cardiac CT scans were
obtained in all patients before PVI, and the PV orientation was measured at the insertion in the LA for all PVs
in both the transverse and frontal plane. PVs were assigned to 1 of 4 orientation groups: ventral–caudal,
dorsal–caudal, ventral–cranial and dorsal–cranial.
Results:Mean agewas 59 years, 88% had paroxysmal AF. AF free survival off anti-arrhythmic drugs after amedian
follow-up of 12 months was 58% after a single PVI procedure. No association was found between PV orientation
and CF. Furthermore, no association was found between PV orientation and AF free survival. In univariate
analysis, the number of lesions with a mean CF of 10 g was associated with AF free survival. However, in
multivariate analysis, only the AF duration was signiﬁcantly associated with AF free survival.
Conclusions: This study shows that in patients undergoing PVI with the CFC ablation system, PV orientation
does not affect CF and is not associated with AF free survival. PV orientation assessment does not appear to be
necessary in patients undergoing CFC PVI.© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Pulmonary vein isolation (PVI) is considered the cornerstone in the
ablative treatment of atrial ﬁbrillation (AF) [1,2]. Multiple techniques
have been developed to perform PVI [3–5]. Currently, the most widely
used technique is point-by-point radiofrequency (RF) ablation guided
by a 3D electro-anatomical mapping system. Earlier reports attempting
to identify geometrical characteristics of pulmonary veins (PVs) that
inﬂuence AF free survival in patients undergoing point-by-point PVI
yielded conﬂicting results [6,7]. A recent study showed that PV orienta-
tion is associated with AF free survival after laser balloon PVI [8]. We
hypothesized that PV orientation inﬂuences optimal contact between
the ablation catheter and atrial tissue, resulting in less durable lesion
sets. The aim of this study was to determine whether PV orientationology, Dr. Van Heesweg 2, 8025
31 38 4243222.
land Ltd. This is an open access articlinﬂuences contact force and AF free survival after PVI with a contact
force sensing catheter ablation system (CFC).
2. Methods
Sixty consecutive patients with highly symptomatic, drug-refractory
AF who underwent a primo PVI using CFC were included. Exclusion
criteria were: previous PVI attempt, severe valvular heart disease and
contraindications to post-procedural anti-coagulation. A transesopha-
geal echocardiogram to rule out LA thrombus was performed in all
patients directly prior to the PVI.
2.1. CT characteristics
All patients underwent CT scanning of the left atrium to guide the
procedure. Cardiac multislice CT (MSCT) angiography was performed
by a team of very experienced CT technologists using a 64-slice scanner
(Lightspeed VCT XT, GE Healthcare). A bolus of 70 ml of nonionic con-
trast medium of agent (Optiray 350, Mallinckrodt, The Netherlands)e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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by 50-ml saline solution ﬂush. Automatic detection of the contrast bolus
in the left atrium was used to time the start of the scan. Delay times
varied signiﬁcantly because of ﬂow rate differences in patients, but
were generally in the range of 5–15 s. Craniocaudal scanning was
performed during breath-hold and using retrospective ECG gating (to
be able to determine volume changes of the LA, but not used in this
study). The collimation was 64 × 0.5 mm, rotation time 400 ms, and
the tube voltage was 120 kV with mA dose modulation variable
between 80 and 200 mA. All images were checked for adequacy before
the end of the procedure to guarantee adequate image quality in all
patients. After acquisition, the raw MSCT data were exported, post-
processed, and analyzed on a dedicated workstation (GE Healthcare).
The images were reviewed by an independent investigator who was
not involved in the CFC guided PVI ablation procedures and was not
informed about the PVI outcome in these patients.
2.2. Pulmonary vein orientation measurement
The PV trunk orientation measurement has been described before
([9,10], Association between pulmonary vein orientation and atrial
ﬁbrillation free survival in patients undergoing endoscopic laser balloon
ablation [8]). The orientation of the PV trunk at the site of insertion into
the LA was assessed for all PVs in both the transverse and frontal plane.
A linewas drawn in the direction of each PV trunk in both the transverse
and frontal plane. Thereafter, the angle between the PV trunk direction
and the intersection line of the sagittal planewasmeasured in the trans-
verse and frontal plane (Fig. 1).Median PV trunk angleswere calculated
in the transverse and frontal plane for all four PV trunks. PVs were
assigned to a ventral/dorsal or caudal/cranial orientation dependingFig. 1. Example of right upper pulmonary vein orientation measurement in the transverse and
frontal plane of the RUPV. In panels A and B, the allocation of the RUPV in this patient in the tra
erence is 98°, as is displayed in panel A. Themedian RUPVdirection in the transverse plane is 10
group. In panels C andD, the allocation of the RUPV of this patient in the frontal plane is displaye
in panel C. The median RUPV direction in the frontal plane is 77°, as can be appreciated from ta
and transverse plane, the RUPV of this patient is categorized to the dorsal–caudal RUPV orienton the PV trunk angle as compared to the median angle. So, each PV
trunk was assigned to one of four orientation groups: ventral–caudal,
dorsal–caudal, ventral–cranial and dorsal–cranial.
2.3. Electrophysiological procedure
All patients underwent CFC guided PVI under general anesthesia
supervised by a cardiovascular anesthesiologist. First, a 6F quadripolar
catheter was placed in the coronary sinus to obtain a procedural intra-
cardiac electrogram. Two transseptal punctures were performed using
a Brockenbrough needle under ﬂuoroscopy and pressure guidance.
10,000 IU of unfractionated heparin was administered after the ﬁrst
transseptal puncture. A circular mapping catheter (LASSO®, Biosense
Webster Inc., Diamond Bar, CA, USA) was inserted into the LA through
an 8.5F sheath (SL-1, St. Jude Medical, Minnetonka, MN, USA) and an
8.5F sheath (SL-1, St. Jude Medical, Minnetonka, MN, USA) was used
for PV angiography. Both sheaths were ﬂushed continuously with a
saline solution containing 2500 UI heparin per 500 ml saline. The
targeted activated clotting time was between 300 and 350 s and addi-
tional heparinwas administeredwhen necessary. The activated clotting
timewas assessed every 30min. The CFC catheterwas inserted in the LA
through an 8.5F sheath and the CFC sensor in the tip electrode was cal-
ibrated after positioning the catheter tip in a free ﬂoating position in the
LA cavity.
2.4. Contact force sensing radiofrequency ablation
The CFC (Smarttouch™, Biosense Webster Inc., Diamond Bar, CA,
USA) [3,11] is an externally irrigated catheter with a 3.5 mm tip elec-
trode. The tip electrode is equipped with a contact force sensor whichfrontal planes. This ﬁgure displays the PV orientation measurement in the transverse and
nsverse plane is displayed. The angle between the PV direction and the sagittal plane ref-
3° as can be appreciated from table 2, categorizing this RUPV to the dorsal RUPV orientation
d. The angle between the PVdirection and the sagittal plane reference is 62°, as is displayed
ble 2, categorizing this RUPV to the caudal RUPV orientation group. Combining the frontal
ation group. PV: pulmonary vein; RUPV: right upper pulmonary vein.
Table 1
Baseline characteristics.
Total (n = 60)
Gender female (%) 23%
Age (years) 59.3 (±9.1)
BMI (kg/m2) 26.9 (±3.5)
AF duration (years) 5.1 (±5.4)
Paroxysmal AF 88%
Failed AADs (range) 1.1 (0–3)
LA dimension in PSLAX (mm) 42.2 (±5.3)
LVEF (%) 58.9 (±3.8)
Hypertension 38%
Previous TIA/stroke 12%
Coronary artery disease 0%
Diabetes 2%
Data are presented as percentages or means ± their SD or ranges where appro-
priate; BMI: body mass index; AF: atrial ﬁbrillation; AAD: anti-arrhythmic
drugs; LA: left atrium; PSLAX: parasternal long axis view; LVEF: left ventricular
ejection fraction. P-values: comparison between AF free and AF recurrence
groups.
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ter system is fully integratedwithin the 3D electro-anatomical mapping
system (CARTO 3™, Biosense Webster Inc., Diamond Bar, CA, USA). PVI
was performed by delivering RF energy in a point-by-point fashion to
the PV antrum creating contiguous circular ablation lesions. RF energy
was applied in a temperature-control mode with a temperature setting
of 43 °C. RF energywas applied at 30Wwith a ﬂow rate of 15ml/min or
at 40Wwith a ﬂow rate of 30ml/min, depending on site of ablation. The
endpoint of the ablation procedure was PV isolation, as documented by
entrance and exit block or dissociation of PV potentials.2.5. Follow-up
A blanking period of 3monthswas deﬁned after PVI. Patients visited
the outpatient clinic at 3, 6, 12, 18 and 24 months after PVI, including
Holter ECG, event recorder monitoring and loop recorder monitoring
in selected cases. Patients were immediately referred to the emergency
room in case of symptoms. 3 months after PVI, an attempt was made in
all patients to cease anti-arrhythmic drugs (AADs).2.6. Study endpoints
The primary endpoint of our study was AF free survival, deﬁned as
patients without AF/atrial ﬂutter/atrial tachycardia recurrence after a
blanking period of 3 months. AF recurrence was deﬁned as an ECG
showing the characteristics of AF, or on a 30 s telemetry strip, in accor-
dance with European Heart Rhythm Association AF ablation guidelines
[1]. Ablation points with a contact force b10 gwere assessed separately,
based on a study that showed adequate lesions are applied with amean
contact force N10 g [12].Table 2
Pulmonary vein characteristics.
Pulmonary vein Median angle Ventral–caudal
Left upper Transverse: 97.1° (±32.0) 28%
Frontal: 139.0° (±19.7)
Left lower Transverse: 62.1° (±17.6) 26%
Frontal: 86.4° (±19.4)
Right upper Transverse: 103.0° (±14.9) 28%
Frontal: 121.8° (±11.4)
Right lower Transverse: 55.5° (±16.2) 20%
Frontal: 77.1° (±14.8)
Data are presented as absolute median or percentages, ± their SD where appropriate.2.7. Statistical analysis
Continuous variables were expressed as mean with standard devia-
tion in case of normal distribution or median with interquartile range
when variables were not normally distributed. Differences in mean
contact force among PV orientation conﬁgurations was assessed
with a Kruskal–Wallis test in case of continuous data and a Chi-square
test in case of categorical data. A univariate and multivariate Cox
proportional hazard model was used to determine predictors of AF
free survival. Statistical analysiswasperformedusing IBMSPSS statistics
version 20 (IBM inc., Armonk, NY, USA). A p-value of ≤0.05 was consid-
ered statistically signiﬁcant.
3. Results
Our study population consisted of sixty consecutive patients.
Baseline characteristics are displayed in Table 1. There were 6 common
PVs (2.6%), which were excluded from analysis. No LA thrombi were
found during preoperative transesophageal echocardiography or CT
scans. Table 2 describes the characteristics of the PV orientation in all
patients.
3.1. Pulmonary vein isolation results
In 234 out of 234 PVs (100%), acute PV isolation after CFC ablation
was conﬁrmed. After a median follow up of 12.3 (interquartile range:
8.3–16.1) months, AF free survival was 57.6% after a single CFC PVI
without the use of class I or III AADs.
3.2. Contact force data
Mean contact force was 15.0 g ± 10.9 for the left upper PV (LUPV),
13.5 g ± 9.7 for the left lower PV (LLPV), 17.9 g ± 10.0 for the right
upper PV (RUPV) and 15.6 g± 9.8 for the right lower PV (RLPV). PV ori-
entationwas not associatedwith contact force for the LUPV (p=0.236),
LLPV (p = 0.491), RUPV (p = 0.143) and RLPV (p = 0.718), as is
displayed in the supplemental Table 1. Furthermore, no association
was found between PV orientation and the number of lesions with a
mean contact force b10 g, as displayed in supplemental Table 2.
3.3. Association with AF free survival
In univariate analysis, none of the baseline characteristics were
associated with AF free survival. Moreover, PV orientation was also
not associated with AF free survival, as is also displayed in Fig. 2.
Table 3 displays the univariate analysis. Of note, mean contact force
was not associated with AF free survival, but the number of ablation
points with a mean contact force b10 g was signiﬁcantly associated
with AF free survival. However, in multivariate analysis, only AF
duration was associated with AF free survival.Dorsal–caudal Ventral–cranial Dorsal–cranial
24% 22% 26%
26% 24% 24%
23% 22% 27%
32% 30% 18%
Fig. 2.Association of pulmonary vein orientation and atrialﬁbrillation free survival. Thisﬁgure displays the association between PV orientation andAF free survival for all four PVs. There is
no signiﬁcant association between PV orientation and AF free survival. P-value between pulmonary vein orientation groups. AF: atrial ﬁbrillation; PV: pulmonary vein.
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This study shows that in patients undergoing PVI with the CFC
ablation system, PV orientation does not affect contact force and is not
associated with AF free survival. These results suggest that durable PV
lesion sets can be delivered independent of PV orientation with the
CFC ablation system. PV orientation assessment does not appear to be
necessary in patients undergoing CFC PVI.Table 3
Univariate and multivariate analysis of AF free survival.
Univariate analysis p-value Hazard ratio 95% CI
Female gender 0.882 1.072 0.428–2
Age 0.560 0.988 0.947–1
BMI 0.605 1.031 0.918–1
Paroxysmal AF 0.115 0.452 0.169–1
AF duration (per year) 0.062 1.053 0.997–1
Failed AADs 0.907 1.032 0.607–1
LA dimension 0.468 1.028 0.954–1
LVEF 0.645 1.028 0.913–1
Hypertension 0.976 0.988 0.440–2
Mean contact force 0.305 0.890 0.711–1
Ablation points with mean contact force b10 g 0.042 1.036 1.001–1
LUPV orientation 0.547
Ventral–caudala 0.643 0.755 0.230–2
Dorsal–caudala 0.712 1.229 0.412–3
Ventral–craniala 0.326 1.765 0.568–5
LLPV orientation 0.641
Ventral–caudala 0.819 0.884 0.308–2
Dorsal–caudala 0.800 1.146 0.399–3
Ventral–craniala 0.285 0.478 0.123–1
RUPV orientation 0.876
Ventral–caudala 0.671 1.258 0.436–3
Dorsal–caudala 0.928 0.947 0.289–3
Ventral–craniala 0.521 1.450 0.467–4
RLPV orientation 0.299
Ventral–caudala 0.536 1.574 0.374–6
Dorsal–caudala 0.793 1.204 0.301–4
Ventral–craniala 0.137 2.644 0.735–9
Univariate and multivariate analysis of the association between patient, procedural and PV cha
AAD: anti-arrhythmic drugs; LA: left atrium; PSLAX: parasternal long axis view; LVEF: left ventr
RUPV: right upper pulmonary vein; RLPV: right lower pulmonary vein. CFC: contact force sens
a As compared to the dorsal–cranial orientation group.4.1. Pulmonary vein anatomy and atrial ﬁbrillation free survival
In a study of 100 patients who underwent RF catheter ablation, a
smaller LA size and an atypical right-sided PV anatomy were associated
with an increased AF free survival after PVI [7]. In another study of 118
patients who underwent RF catheter ablation, the absence of common
PV trunks was associated with an increased AF free survival [13]. How-
ever, none of these studies assessed the association between PVMultivariate analysis p-value Hazard ratio 95% CI
.687 Ablation points with mean
contact force b10 g
0.333 1.017 0.983–1.053
.030 AF duration (per year) 0.017 1.128 1.021–1.246
.158
.212
.112
.755
.107
.159
.216
.112
.072
.481
.665
.488
.536
.287
.852
.628
.103
.505
.618
.820
.513
racteristics and AF free survival after CFC PVI. BMI: bodymass index; AF: atrial ﬁbrillation;
icular ejection fraction. LUPV: left upper pulmonary vein; LLPV: left lower pulmonary vein;
ing catheter ablation system. P-values between AF free and AF recurrence groups.
5P. Gal et al. / IJC Heart & Vasculature 8 (2015) 1–5orientation and AF free survival, although in a recent study, PV orienta-
tionwas signiﬁcantly associatedwith AF free survival after laser balloon
PVI [9].
4.2. Contact force sensing catheter system characteristics
The CFC allows contact force guided RF ablation of AF. Previous
studies found an association between pressure–time curves recorded
with the CFC and AF free survival, indicating that contact force sensing
may assist in the application of durable lesion sets [14,15]. The present
study is in line with these results, showing that the number of lesions
with a contact force b10 g was associated with a diminished AF free
survival. Hypothetically, pressure-guided ablation should allow the
operator to identify inadequate lesions and apply additional ablations
when deemed necessary.
4.3. Pulmonary vein orientation and AF free survival
AF recurrences are generally regarded as reconnection between the
PV and the LA allowing electrical reconduction [16,17]. Therefore the
durability of the applied circumferential lesions are essential in
preventing AF recurrences. Hypothetically, the inﬂuence of PV orienta-
tion may be negated by allowing the operator to identify inadequate
catheter-tissue contact due to PV orientation, and increase catheter–
tissue contact accordingly, resulting in durable lesion sets.
4.4. Limitations
With regards to interpreting our data, the following limitations
should be considered. This is a single center study with a limited
number of patients. The patient cohort was limited to those having no
or minimal structural heart disease and a normal left ventricular
function.
5. Conclusion
This study showed that in patients undergoing PVI with the CFC
ablation system, PV orientation does not affect contact force and is not
associated with AF free survival. PV orientation assessment does not
appear to be necessary in patients undergoing CFC PVI.
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